Showing results (131-140 of 200) with videos related to
Sort By:
Pageof 20
Brain Research|June 19, 1998
Age-related decline in striatal dopamine release and motoric function in brown Norway/Fischer 344 hybrid ratsD M Yurek, S B Hipkens, M A Hebert, et al.Brain Research|January 16, 1999
GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeysG A Gerhardt, W A Cass, P Huettl, et al.Magnetic Resonance Imaging|January 1, 1996
Mapping drug-induced changes in cerebral R2* by Multiple Gradient Recalled Echo functional MRIQ Chen, A H Andersen, Z Zhang, et al.Annals of Neurology|June 1, 1994
Antiparkinsonian effects of remacemide hydrochloride, a glutamate antagonist, in rodent and primate models of Parkinson's diseaseJ T Greenamyre, R V Eller, Z Zhang, et al.Physiology & Behavior|January 1, 1986
Behavioral variability within the Brattleboro and Long-Evans rat strainsJ P Herman, G J Thomas, J F Laycock, et al.Science (New York, N.Y.)|September 26, 1986
Amitotic neuroblastoma cells used for neural implants in monkeysD M Gash, M F Notter, S H Okawara, et al.Neuroscience|January 1, 1990
Cografts of adrenal medulla with C6 glioma cells in rats with 6-hydroxydopamine-induced lesionsG Bing, M F Notter, J T Hansen, et al.Journal of Neuroscience Methods|September 24, 1999
An automated movement assessment panel for upper limb motor functions in rhesus monkeys and humansD M Gash, Z Zhang, G Umberger, et al.Neuroscience|October 8, 1997
Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus)J R Taylor, J D Elsworth, R H Roth, et al.Neuroscience Letters|October 20, 1986
Aged mice are more sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment than young adultsM Gupta, B K Gupta, R Thomas, et al.Pageof 20